                         SEQUENCE LISTING

<110>  The Regents of the University of California
 
<120>  METHODS AND COMPOSITIONS FOR THE LABELING AND SELECTION OF 
       ANTIGEN-SPECIFIC T-CELLS

<130>  UCLA.P0135WO/1001197016

<150>  63/141,374
<151>  2021-01-25

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  1

Met Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   10  


<210>  2
<211>  15
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  2

Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
1               5                   10                  15  


<210>  3
<211>  26
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  3

Lys Arg Arg Trp Lys Lys Asn Phe Ile Ala Val Ser Ala Ala Asn Arg 
1               5                   10                  15      


Phe Lys Lys Ile Ser Ser Ser Gly Ala Leu 
            20                  25      


<210>  4
<211>  13
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  4

Gly Ala Pro Val Pro Tyr Pro Asp Pro Leu Glu Pro Arg 
1               5                   10              


<210>  5
<211>  8
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  5

Asp Tyr Lys Asp Asp Asp Asp Lys 
1               5               


<210>  6
<211>  9
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  6

Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   


<210>  7
<211>  10
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  7

Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
1               5                   10  


<210>  8
<211>  38
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  8

Met Asp Glu Lys Thr Thr Gly Trp Arg Gly Gly His Val Val Glu Gly 
1               5                   10                  15      


Leu Ala Gly Glu Leu Glu Gln Leu Arg Ala Arg Leu Glu His His Pro 
            20                  25                  30          


Gln Gly Gln Arg Glu Pro 
        35              


<210>  9
<211>  13
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  9

Ala His Ile Val Met Val Asp Ala Tyr Lys Pro Thr Lys 
1               5                   10              


<210>  10
<211>  12
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  10

Lys Leu Gly Asp Ile Glu Phe Ile Lys Val Asn Lys 
1               5                   10          


<210>  11
<211>  34
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  11

Val Gln Leu Ala His His Phe Ser Glu Pro Glu Ile Thr Leu Ile Ile 
1               5                   10                  15      


Phe Gly Val Met Ala Gly Val Ile Gly Thr Ile Leu Leu Ile Ser Tyr 
            20                  25                  30          


Gly Ile 
        


<210>  12
<211>  4
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  12

Gly Ser Gly Gly 
1               


<210>  13
<211>  8
<212>  PRT
<213>  artificial squence

<220>
<223>  Synthetic Polypeptide

<400>  13

Gly Ser Gly Gly Gly Ser Gly Gly 
1               5               


